Clinical Trial Update: Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy of vortioxetine on cognitive dysfunction in working adults with major depressive disorder. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED